Search Results - "Jiao, Shiping"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Unraveling the spatial organization and development of human thymocytes through integration of spatial transcriptomics and single-cell multi-omics profiling by Li, Yanchuan, Li, Huamei, Peng, Cheng, Meng, Ge, Lu, Yijun, Liu, Honglin, Cui, Li, Zhou, Huan, Xu, Zhu, Sun, Lingyun, Liu, Lihong, Xiong, Qing, Sun, Beicheng, Jiao, Shiping

    Published in Nature communications (06-09-2024)
    “…The structural components of the thymus are essential for guiding T cell development, but a thorough spatial view is still absent. Here we develop the TSO-his…”
    Get full text
    Journal Article
  3. 3

    Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis by Yan, Xueqi, Xie, Yinghong, Yang, Fan, Hua, Yijia, Zeng, Tianyu, Sun, Chunxiao, Yang, Mengzhu, Huang, Xiang, Wu, Hao, Fu, Ziyi, Li, Wei, Jiao, Shiping, Yin, Yongmei

    “…Breast cancer is a heterogeneous disease with a complex microenvironment consisting of tumor cells, immune cells, fibroblasts and vascular cells. These…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling by Jiao, Shiping, Xiong, Qing, Yan, Meisi, Zhan, Xiaolu, Yang, Zhenhuang, Peng, Cheng, Sun, Beicheng, Pang, Da, Liu, Tong

    Published in Journal for immunotherapy of cancer (01-01-2022)
    “…BackgroundSentinel lymph nodes (LNs) are regarded as key immune surveillance sites in cancer wherein mature dendritic cells present tumor-derived antigens to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer by Jiao, Shiping, Wu, Minqing, Ye, Feng, Tang, Hailin, Xie, Xinhua, Xie, Xiaoming

    Published in PloS one (17-03-2014)
    “…Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and…”
    Get full text
    Journal Article
  8. 8

    Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study by Jiao, Shiping, Liu, Wenjie, Wu, Minqing, Peng, Cheng, Tang, Hailin, Xie, Xiaoming

    “…Existing reports showed loss of Nrdp1, an E3 ubiquitin ligase, promoted breast cancer malignancy because of failure to deregulate ErbB3. However, the…”
    Get more information
    Journal Article
  9. 9

    Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy by Jiao, Shiping, Subudhi, Sumit K., Aparicio, Ana, Ge, Zhongqi, Guan, Baoxiang, Miura, Yuji, Sharma, Padmanee

    Published in Cell (14-11-2019)
    “…Immune checkpoint therapy (ICT) shows encouraging results in a subset of patients with metastatic castration-resistant prostate cancer (mCRPC) but still…”
    Get full text
    Journal Article
  10. 10

    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer by Yamaguchi, H, Du, Y, Nakai, K, Ding, M, Chang, S-S, Hsu, J L, Yao, J, Wei, Y, Nie, L, Jiao, S, Chang, W-C, Chen, C-H, Yu, Y, Hortobagyi, G N, Hung, M-C

    Published in Oncogene (11-01-2018)
    “…Inhibitors against poly (ADP-ribose) polymerase (PARP) are promising targeted agents currently used to treat BRCA -mutant ovarian cancer and are in clinical…”
    Get full text
    Journal Article
  11. 11

    Abstract 6665: A spatiotemporal cell atlas of human gastric malignancy reveals mechanisms underlying metastasis and immunotherapy response by Luo, Yikai, Kang, Muxing, Liu, Wei, Jiao, Shiping, Wang, Lie, Chen, Jian, Liang, Han

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Cellular heterogeneity in the tumor immune microenvironment (TIME) of gastric cancer (GC) is progressively molded in pre- and early-malignant lesions…”
    Get full text
    Journal Article
  12. 12

    BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer: e92172 by Jiao, Shiping, Wu, Minqing, Ye, Feng, Tang, Hailin, Xie, Xinhua, Xie, Xiaoming

    Published in PloS one (01-03-2014)
    “…Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and…”
    Get full text
    Journal Article